ALPINE IMMUNE SCIENCES, INC. Annual Deferred Income Tax Expense (Benefit) in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Alpine Immune Sciences, Inc. annual/quarterly Deferred Income Tax Expense (Benefit) history and growth rate from 2016 to 2023.
  • Alpine Immune Sciences, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending June 30, 2022 was $100K.
  • Alpine Immune Sciences, Inc. annual Deferred Income Tax Expense (Benefit) for 2023 was $155K, a 237% increase from 2022.
  • Alpine Immune Sciences, Inc. annual Deferred Income Tax Expense (Benefit) for 2022 was $46K.
  • Alpine Immune Sciences, Inc. annual Deferred Income Tax Expense (Benefit) for 2021 was -$214K.
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $155K +$109K +237% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-20
2022 $46K +$260K Jan 1, 2022 Dec 31, 2022 10-K 2024-03-20
2021 -$214K -$214K Jan 1, 2021 Dec 31, 2021 10-K 2024-03-20
2020 $0 $0 Jan 1, 2020 Dec 31, 2020 10-K 2023-03-23
2019 $0 +$305K Jan 1, 2019 Dec 31, 2019 10-K 2022-03-17
2018 -$305K -$101K -49.5% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-18
2017 -$204K -$204K Jan 1, 2017 Dec 31, 2017 10-K 2020-03-30
2016 $0 Jan 1, 2016 Dec 31, 2016 10-K 2019-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.